B Group, Inc.
Reporting owner on Forms 3, 4 and 5, CIK 2043476.
- Also a 13F filer: B Group, Inc.
- In the filer group B Group, Inc.
B Group, Inc. reported on 1 issuer in 10 filings, the latest a 13F-HR filed 2026-11-16.
Issuers
| Issuer | Roles in the latest filing | Filings | Last filed |
|---|---|---|---|
| Retension Pharmaceuticals, Inc. CIK 2002988 | 10% owner | 1 | 2026-10-16 |
Transactions and holdings
Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.
| Security | Date | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| Retension Pharmaceuticals, … Common Stock, holding | 833,333 | Form 3 |
Filings
The person's Forms 3, 4 and 5, and any 13D or 13G naming it.
| Filing | Subject | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001420506-26-002733 | Quarter ended 2026-09-30 | 2026-11-16 | ||
| Form 3 0001213900-26-110379 | Retension Pharmaceuticals, Inc. | 2026-10-16 | ||
| 13G 0001213900-26-110378 | RTSN | 2026-10-16 | ||
| 13F-HR 0001420506-26-001657 | Quarter ended 2026-06-30 | 2026-08-14 | acceptance time not in the bulk data set | |
| 13F-HR 0001420506-26-001023 | Quarter ended 2026-03-31 | 2026-05-15 | acceptance time not in the bulk data set | |
| 13F-HR 0001420506-26-000462 | Quarter ended 2025-12-31 | 2026-02-17 | acceptance time not in the bulk data set | |
| 13F-HR 0001420506-25-003231 | Quarter ended 2025-09-30 | 2025-11-14 | acceptance time not in the bulk data set | |
| 13F-HR 0001420506-25-002005 | Quarter ended 2025-06-30 | 2025-08-14 | acceptance time not in the bulk data set | |
| 13F-HR 0001420506-25-001152 | Quarter ended 2025-03-31 | 2025-05-15 | acceptance time not in the bulk data set | |
| 13F-HR 0001420506-25-000436 | Quarter ended 2024-12-31 | 2025-02-14 | acceptance time not in the bulk data set |